Dr. Nicholas J. Agresti, MD

Dr. Agresti practices at Jacksonville Center for Endoscopy Riverside in Jacksonville, Florida.

Dr. Agresti's NPI, 1669634010, was assigned on June 26, 2008. Dr. Agresti graduated from American University of the Caribbean School of Medicine in 2008. Dr. Agresti holds Florida license ME115292.

Dr. Agresti's primary practice is Jacksonville Center for Endoscopy Riverside, at 1610 Barrs St Suite B, Jacksonville, FL 32204. The practice phone is (904) 387-6750.

Dr. Agresti's primary practice is Jacksonville Center for Endoscopy Riverside in Jacksonville, Florida. Dr. Agresti is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Borland Groover. Dmand AI also links Dr. Agresti to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Agresti practices, 7 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Agresti's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Agresti is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Agresti's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Agresti treats.

CMS data shows 817 Medicare services from Dr. Agresti across 11 procedure codes in 2024, for 451 Medicare patients. Medicare paid $86,898 for them.

CMS counts 451 Medicare patients who saw Dr. Agresti in 2024. The largest group is 65 to 74, with 207 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Agresti's median patient age at 63, with 59% women.

In 2024, Dr. Agresti wrote 678 Medicare Part D claims for 245 patients. 71% of them were for generic drugs. CMS names the drug for 502 of them, across 18 drugs with 11 or more claims each, at $992,231 in total drug cost. In 2023, CMS named 420 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Agresti for performance year 2024, reported as part of a group. Dr. Agresti accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Agresti as offering telehealth. CMS counts 122 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Agresti, more than 81% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Agresti, published from 2015 to 2021. 2021 was the busiest year, with 2. Dr. Agresti's most frequent co-authors are Seth Andrew Gross, MD, Juan Carlos Munoz, MD and Ahmad Alkaddour, MD.

CMS Open Payments shows 666 general payments to Dr. Agresti from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $3,522.

Dr. Agresti graduated from American University of the Caribbean School of Medicine in 2008.

Dr. Agresti is in network with 18 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.